Dr. Aplan is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Aplan's full profile

Already have an account?

  • Office

    Nih Nci Nnmc Bldg 8 Rm 5101
    8901 Rockville Pike
    Bethesda, MD 20889
    Phone(301) 435-5005
    Fax(301) 496-0047
  • Is this information wrong?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFELLOWSHIP
  • Kaleida Health System - Children HospitalRESIDENCY
  • Penn State College of Medicine
    Penn State College of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1987 - 2022
  • American Board of Pediatrics Pediatrics

Publications & Presentations

PubMed

Abstracts/Posters

  • Disruption of the Normal Hematopoietic Hierarchy Leading to Stem Cell Exhaustion in an Animal Model of Myelodysplastic Syndrome
    Peter D. Aplan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Idh2R140Q Cooperates with NHD13 to Induce Immature T Cell Leukemia By Targeting Early T Cell Progenitors or DN2 Thymocytes
    Peter D. Aplan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Engineered Bcor Mutations Lead to Acute Lymphoblastic Leukemia of Progenitor B-1 Lymphocyte Origin in a Sensitized Background 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Mice with a Unique Mutator Phenotype Allow Detection of Lymphoid Leukemia Tumor Suppressor Genes 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • A Novel DNA Methyltransferase Inhibitor Is Effective in an In Vivo Model of Myelodysplastic Syndrome 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Grant Support

  • Pre-Clinical Studies Of Therapy For Myelodysplastic SyndromeNational Cancer Institute2010–2011
  • Mechanisms Of Chromosomal TranslocationNational Cancer Institute2010–2011
  • Collaborative Pathways That LEAD To LeukemiaNational Cancer Institute2010–2011
  • Activation Of Proto-Oncogenes By Chromosomal TranslocationNational Cancer Institute2010–2011
  • Mechanisms Of Chromosomal TranslocationDivision Of Clinical Sciences - Nci2009
  • Activation Of Proto-Oncogenes By Chromosomal TranslocationDivision Of Clinical Sciences - Nci2009
  • Pre-Clinical Studies Of Therapy For Myelodysplastic SyndromeDivision Of Basic Sciences - Nci2009
  • Collaborative Pathways That LEAD To LeukemiaDivision Of Basic Sciences - Nci2009
  • Pre-Clinical Studies Of Therapy For Myelodysplastic SyndromeNational Cancer Institute2008
  • Mechanisms Of Chromosomal TranslocationNational Cancer Institute2007–2008
  • Activation Of Proto-Oncogenes By Chromosomal TranslocationNational Cancer Institute2007–2008
  • Activation Of Proto-Oncogenes By Chromosomal TranslocatiDivision Of Clinical Sciences - Nci2002–2006
  • Mechanisms Of Chromosomal TranslocationDivision Of Clinical Sciences - Nci2001–2006
  • Activation Of Proto-Oncogenes--Chromosomal TranslocationDivision Of Clinical Sciences - Nci2001
  • SCL Gene Dysregulation And T Cell LeukemiaNational Cancer Institute1996–1999
  • Chromosomal Translocations Caused By TOPO II InhibitorsNational Cancer Institute1997–1998